Evidence map›Paper›PMID 23255504›Full record

ArticleHuman mutation2013

Mutations in CCDC39 and CCDC40 are the major cause of primary ciliary dyskinesia with axonemal disorganization and absent inner dynein arms.

Dinu Antony, Anita Becker-Heck, Maimoona A Zariwala, Miriam Schmidts, Alexandros Onoufriadis, Mitra Forouhan, Robert Wilson, Theresa Taylor-Cox, Ann Dewar, Claire Jackson and 25 more

2 registry-linked trialsOpen access · greenAbstract read
In one paragraph

Article in Human mutation, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 114 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
114citing papers in PubMed, 4 pooled it
9.1field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT00450918 completednot on this map

Longitudinal Study of Primary Ciliary Dyskinesia: Participants 5-18 Years of Age

TypeobservationalSponsorUniversity of North Carolina, Chapel HillRan2006 to 2019Enrolled150ConditionsPrimary Ciliary Dyskinesia
NCT00722878 completednot on this map

Early Onset and Progression of Primary Ciliary Dyskinesia Lung Disease Prior to 10 Years of Age

TypeobservationalSponsorUniversity of North Carolina, Chapel HillRan2008 to 2019Enrolled48ConditionsKartagener Syndrome
3 · Its place in the literature

Who cites it

114 citing papers in PubMed, 4 syntheses or guidelines pooled it, 190 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Guideline
  4. Guideline
  5. Trial
  6. mRNA therapy improves the composition and motility in CCDC40-deficient cilia in vitro and in vivo.American journal of respiratory cell and molecular biology · 2026
    Article
  7. Science advances · 2026
    Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Clinical development of therapeutic mRNA applications.Molecular therapy : the journal of the American Society of Gene Therapy · 2025
    Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article

54 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

35 authors at 13 institutions in 4 countries.

Dinu AntonyMolecular Medicine Unit and Birth Defects Research Centre, University College London (UCL) Institute of Child Health, London, UK.
Anita Becker-Heck
Maimoona A Zariwala
Miriam Schmidts
Alexandros Onoufriadis
Mitra Forouhan
Robert Wilson
Theresa Taylor-Cox
Ann Dewar
Claire Jackson
Patricia Goggin
Niki T Loges
Heike Olbrich
Martine Jaspers
Mark Jorissen
Margaret W Leigh
Whitney E Wolf
M Leigh Anne Daniels
Peadar G Noone
Thomas W Ferkol
Scott D Sagel
Margaret Rosenfeld
Andrew Rutman
Abhijit Dixit
Christopher O'Callaghan
Jane S Lucas
Claire Hogg
Peter J Scambler
Richard D Emes
Uk10k
Eddie M K Chung
Amelia Shoemark
Michael R Knowles
Heymut Omran
Hannah M Mitchison
University College London · GBUniversity of North Carolina Health Care · USRoyal Brompton & Harefield NHS Foundation Trust · GBUniversity Hospital Münster · DEUniversity of Southampton · GBKU Leuven · BELeicester Royal Infirmary · GBNottingham City Hospital · GBSeattle Children's Hospital · USUniversity of Colorado Denver · USUniversity of Leicester · GBUniversity of Nottingham · GBWashington University in St. Louis · US

Funding

Colorado Clinical and Translational Sciences InstituteUL1TR001082 · NCATS · UNIVERSITY OF COLORADO DENVER · PI SOKOL, RONALD J. · 2013 to 2017
$48.0M
Zonisamide in Patients with Neuropathic Pain Associated with Diabetic NeuropathyM01RR000046 · NCRR · UNIV OF NORTH CAROLINA CHAPEL HILL · PI JOY, MELANIE S · 1985 to 2008
$38.5M
Colorado Clinical and Translational Science Institute (UL1)UL1TR000154 · NCATS · UNIVERSITY OF COLORADO DENVER · PI SOKOL, RONALD J. · 2012 to 2013
$20.4M
Longitudinal Characterization of Respiratory Tract Exacerbations and Treatment Responses in Primary Ciliary DyskinesiaU54HL096458 · NHLBI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI DAVIS, STEPHANIE DUGGINS, FERKOL, THOMAS W · 2009 to 2023
$20.0M
UNC Clinical and Translational Science AwardUL1TR000083 · NCATS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI RUNGE, MARSCHALL S. · 2012 to 2013
$11.6M
TRAINING IN RESPIRATORY AND ENVIRONMENTAL MEDICINET32HL007106 · NHLBI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI BOUCHER, RICHARD CHARLES, DOERSCHUK, CLAIRE M · 1985 to 2021
$7.3M
Pathogenesis of PCD Lung DiseaseR01HL071798 · NHLBI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI KNOWLES, MICHAEL R · 2004 to 2021
$7.2M
British Heart Foundation RG/10/13/28570Department of Health NF-SI-0510-10268Medical Research Council MR/K000608/1NCATS NIH HHS UL1 TR000083NCATS NIH HHS UL1 TR000154NCATS NIH HHS UL1 TR001082NCRR NIH HHS M01 RR000046NHLBI NIH HHS 5 R01HL071798NHLBI NIH HHS 5 U54 HL096458-06NHLBI NIH HHS R01 HL071798NHLBI NIH HHS T32 HL007106NHLBI NIH HHS U54 HL096458PHS HHS ULITR000083Wellcome Trust 090532Wellcome Trust 091551Wellcome Trust WT091310
6 · The paper itself

Abstract

Primary ciliary dyskinesia (PCD) is a genetically heterogeneous disorder caused by cilia and sperm dysmotility. About 12% of cases show perturbed 9+2 microtubule cilia structure and inner dynein arm (IDA) loss, historically termed "radial spoke defect." We sequenced CCDC39 and CCDC40 in 54 "radial spoke defect" families, as these are the two genes identified so far to cause this defect. We discovered biallelic mutations in a remarkable 69% (37/54) of families, including identification of 25 (19 novel) mutant alleles (12 in CCDC39 and 13 in CCDC40). All the mutations were nonsense, splice, and frameshift predicting early protein truncation, which suggests this defect is caused by "null" alleles conferring complete protein loss. Most families (73%; 27/37) had homozygous mutations, including families from outbred populations. A major putative hotspot mutation was identified, CCDC40 c.248delC, as well as several other possible hotspot mutations. Together, these findings highlight the key role of CCDC39 and CCDC40 in PCD with axonemal disorganization and IDA loss, and these genes represent major candidates for genetic testing in families affected by this ciliary phenotype. We show that radial spoke structures are largely intact in these patients and propose this ciliary ultrastructural abnormality be referred to as "IDA and microtubular disorganisation defect," rather than "radial spoke defect."

Indexed as

MutationAllelesAxonemeCiliaCytoskeletal ProteinsDyneinsExomeFemaleFluorescent Antibody TechniqueHumansKartagener SyndromeMaleMicroscopy, ElectronPedigreePhenotypeProteinsCCDC39 protein, humanCCDC40 protein, humanCytoskeletal ProteinsDyneinsProteins

Identifiers

PMID23255504
PMCPMC3630464
OpenAlexW2131455138

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.